Patricia Gómez Pardo (Patricia Gómez)

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 5

Top Topics

Atomic Force Microscopy

Metastatic Breast Cancer

Epidermal Growth Factor Receptor

High Performance Liquid Chromatography

Top Venues

International journal of molecular sciences

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Emma Franco-Mateos, Virginia Souza-Egipsy, Laura García-Estévez, José Pérez-García, María Gion, Laia Garrigós, Patricia Cortez, Cristina Saavedra, Patricia Gómez Pardo, Carolina Ortiz, Víctor L Cruz, Javier Ramos, Javier Cortés, Juan F Vega
Exploring the Combined Action of Adding Pertuzumab to Branded Trastuzumab versus Trastuzumab Biosimilars for Treating HER2+ Breast Cancer. International journal of molecular sciences 25 (7) (2024)
Emma Franco-Mateos, Virginia Souza-Egipsy, Laura García-Estévez, José Pérez-García, María Gion, Laia Garrigós, Patricia Cortez, Cristina Saavedra, Patricia Gómez Pardo, Carolina Ortiz, Víctor L Cruz, Javier Ramos, Javier Cortés, Juan F Vega
Exploring the Combined Action of Adding Pertuzumab to Branded Trastuzumab versus Trastuzumab Biosimilars for Treating HER2+ Breast Cancer. International journal of molecular sciences 25 (7) (2024)
Emma Franco-Mateos, Virginia Souza-Egipsy, Laura García-Estévez, José Pérez-García, María Gion, Laia Garrigós, Patricia Cortez, Cristina Saavedra, Patricia Gómez Pardo, Carolina Ortiz, Víctor L Cruz, Javier Ramos, Javier Cortés, Juan F Vega
Exploring the Combined Action of Adding Pertuzumab to Branded Trastuzumab versus Trastuzumab Biosimilars for Treating HER2+ Breast Cancer. International journal of molecular sciences 25 (7) (2024)
Emma Franco-Mateos, Virginia Souza-Egipsy, Laura García-Estévez, José Pérez-García, María Gion, Laia Garrigós, Patricia Cortez, Cristina Saavedra, Patricia Gómez Pardo, Carolina Ortiz, Víctor L Cruz, Javier Ramos, Javier Cortés, Juan F Vega
Exploring the Combined Action of Adding Pertuzumab to Branded Trastuzumab versus Trastuzumab Biosimilars for Treating HER2+ Breast Cancer. International journal of molecular sciences 25 (7) (2024)
Hope S Rugo, Aditya Bardia, Frederic Marmé, Javier Cortes, Peter Schmid, Delphine Loirat, Olivier Trédan, Eva Ciruelos Gil, Florence Dalenc, Patricia Gómez Pardo, Komal L Jhaveri, Rosemary Delaney, Olivia Fu, Lanjia Lin, Wendy Verret, Sara M Tolaney
Sacituzumab Govitecan in Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (29) (2022)